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ABSTRACT
Objective: The objective of this study as to characterize the genotoxicity of reactive metabolites of 2,6-dimethylaniline (2,6-DMA) and 3,5-DMA in the 
hypoxanthineguanine phosphoribosyltransferase (HPRT) gene of human lymphoblastoid TK6 cells.
Methods: Cultures were exposed to N-hydroxylamine and aminophenol metabolites of 2,6- and 3,5-DMA for 1 h in serum-free medium. Cell survival 
24 h after exposure was determined by trypan blue exclusion. Cells were then subcultured for 7–10 days to allow to phenotypic expression of HPRT 
mutants. After the expression period, cells were plated in the presence of  2 µg/ml 6-thioguanine for the selection of HPRT mutants. Plating efficiency was 
determined and mutant fraction calculated. Electron paramagnetic resonance (EPR) was also used to determine whether 3,5- dimethylaminophenol 
(DMAP) produced reactive oxygen species (ROS).
Results: All of the metabolites tested were cytotoxic to these cells but exhibited a considerable variation in potency. The aminophenol metabolites of 
2,6- and 3,5-DMA were considerably more toxic than the corresponding N-hydroxylamines. Furthermore, each metabolite of 3,5-DMA was more toxic 
than its 2,6-DMA counterpart; N-OH-3,5-DMA and 3,5-DMAP were clearly mutagenic at a level of 50 µM. EPR studies showed intracellular oxidative 
stress induced under 3,5-DMAP treatment.
Conclusions: Our findings suggest that genotoxic responses of 2,6- and 3,5-DMA are mediated through the generation of ROS by hydroxylamine and/
or aminophenol metabolites.
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INTRODUCTION
Alkylanilines are abundantly found environmental chemicals, mainly 
tobacco smoke and hair dyes. They are considered factors for the 
development of bladder cancer [1]. Most common alkylanilines in the 
environment are 2,6-dimethylaniline (2,6-DMA) and 3,5-dimethylaniline 
((3,5-DMA). They are metabolized by CYP450s to N-hydroxy-DMA 
through N-hydroxylation or dimethylaminophenol (DMAP), which can 
further be metabolized to dimethylquinone imine and then go through 
redox cycling to generate reactive oxygen species (ROS) [1,2].
Although 2,6-DMA has been shown to be clearly mutagenic for 
Salmonella typhimurium and a rodent nasal cavity carcinogen [3], 
categorized by IARC as possibly carcinogenic to humans (Group 2B), 
and it has been shown to form DNA adducts in rats [4], evidence linking 
exposure to 3,5-DMA, which are structurally closed related to 2,6-DMA, to 
genotoxicity or carcinogenicity is less extensive. Recently, the mutagenic 
potential of 3,5-DMA was assessed in the gpt gene of AS52 cells and 
aprt gene of AA8 cells [2,5,6]. 3,5-DMA was mutagenic and cytotoxic in 
AS52 cells when activated by P450-mediated hydroxylation and phase II 
conjugation, in which the aminophenol metabolites were considerably 
more potent than the corresponding N-hydroxylamines [2,5], whereas 
3,5-DMAP did not caused a statistically significant increase in mutation 
frequency in AA8 cells [5,6]. In the absence of animal models, in vitro 
studies become particularly important in providing information on the 
carcinogenic mechanisms of 3,5-DMA. Therefore, all agree that other 
assays require further study for the understanding of mutagenesis 
caused by 3,5-DMA and its metabolites. The most promising mutation 
assays seem to be the hypoxanthine phosphoribosyltransferase (HPRT) 
assay. The HPRT gene is on the X chromosome of mammalian cells, and 
it is used as a model gene to investigate gene mutations in mammalian 
cell lines [7]. The assay can detect a wide range of chemicals capable of 
causing DNA damage that leads to gene mutation [7].
In the present study, we have begun testing the hypothesis that their 
genotoxic effects are mediated through N-hydroxylamine and/or 
aminophenol metabolites. Target cells used for these experiments include 
human lymphoblastoid TK6 cells, which have been used extensively in 
mutagenicity studies. We also used electron paramagnetic resonance 
(EPR) to test ROS production by aminophenol metabolites of DMA.
METHOD
Chemicals and reagents
Reagents and cell culture materials were purchased from the following 
sources: Cell culture materials, Lonza (Walkersville, MD); fetal bovine 
serum, Atlanta Biological; 2,6-DMA, 6-thioguanine (6-TG), 5,5-dimethyl-
1-pyrroline N-oxide (DMPO), and dimethyl sulfoxide (DMSO), Sigma 
Chemical Co., St Louis, MO; superoxide dismutase (SOD, 5000 U mg) and 
beef liver catalase (CAT, 65000 U/mg), Roche Diagnostics (Indianapolis, 
IN, US); and 3,5-DMA, Acros Organics (Geel, Belgium).
Cell cultures
TK6 cells, provided by Dr. Wogan (Massachusetts Institute of 
Technology), were maintained in RPMI 1640 medium supplemented 
with antibiotics and 10% heat-inactivated horse serum (Lonza, 
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Walkersville, MD). Before each experiment, they were treated with CHAT 
(10 µM 2´-deoxycytidine, 20 µM hypoxanthine, 0.1 µM aminopterin, and 
17.5 µM thymidine) according to a standard protocol to remove pre-
existent mutant cells.
Treatments with N-hydroxy and aminophenol metabolites of 
2,6- and 3,5-DMA
N-hydroxy and aminophenol metabolites of 2,6- and 3,5-DMA were 
synthesized as described previously [5]. The cells were seeded at 1×106 
and incubated overnight with the regular medium. Then, medium 
changed to one without serum and cells were treated in triplicate with 
0–250 µM of N-hydroxy or aminophenol metabolites for 1, 2, 4, and 
24 h. After treatment, the culture was washed with PBS, amended with 
RPMI 1640 medium containing 10% horse serum, and incubated.
Measurement of survival and HPRT mutations
Cytotoxicity was determined by trypan blue exclusion assay 24 h after 
treatment. Specifically, conditions were chosen which resulted in 35–
50% survival 1 h after exposure because previous studies shown that 
such conditions optimize statistical estimation of MF [8,9]. TK6 cells 
were maintained for 7 days to allow phenotypic expression, at which 
time a total of 24×106 cells were placed into ten 96-well microtiter plates 
at densities of 4×104 cells/well in medium containing 2 µg/mL of 6-TG to 
select HPRT mutants, respectively. For plating efficiency, cells from each 
culture were also plated into 96-well dishes at 1 cell/100 μL/well in the 
absence of selective agents. After 2 weeks of incubation, colonies were 
counted and mutation fractions (MFs) were calculated as described by 
Kim [10]. Identified single HPRT mutant colony was then transferred 
to 24-well plates for propagating mutant cells. Approximately 2×106 
mutant cells were collected for molecular analysis. The spontaneous 
MF was estimated from the argon-treated cells for NO• treatment or 
untreated cells for coculture. Cells treated with 4-NQO (140 ng/mL for 
1.5 h) served as positive controls.
EPR spectroscopy
TK6 cells (1×107) were gently washed twice with RPMI-serum-free media 
and then resuspended 400 µL of serum-free media. An aliquot of 400 µL 
was mixed with DMPO (100 mM), 3,5-DMAP (2 mM), and NADPH (15 mM) 
and placed into flat cell. Measurements were carried out using 0.3-mm 
flat cell. All reaction mixtures were air-saturated for the EPR experiments. 
EPR experiment run by a Broker EMX-300 spectrometer (Bruker, Billerica, 
MA) operating at modulation frequency 100 kHz; microwave frequency, 
9.17 GHz; modulation amplitude, 0.5 G; and receiver gain, 1×104.
Statistical analysis
All experiments were repeated 2–4 times. The two-tailed Student’s 
t-test (SPSS for Windows, 12.0, SPSS Inc. Chicago, IL, USA) was used for 
the comparison of test and control groups, and p<0.05 and 0.01 were 
considered to be statistically significant.
RESULTS AND DISCUSSION
Time-course analysis of cell survival
To determine the suppression of cell growth by N-hydroxy and 
aminophenol metabolites of 2,6- and 3,5-DMA in human lymphoblastoid 
cells, TK6 cells were treated with various doses of N-hydroxy and 
aminophenol metabolites of 2,6- and 3,5-DMA for 1, 2, 4, or 24 h. 
As shown in Table 1, N-hydroxy and aminophenol metabolites of 
2,6- and 3,5-DMA exerted cell growth inhibitory effects on TK6 cells 
in a dose- and time-dependent manner. The growth of the TK6 cells 
was markedly suppressed following 24 h treatment with the highest 
concentrations of each metabolite, N-hydroxy-2,6- and 3,5-DMA (250 
and 100 µM), and 2,6- and 3,5-DMAP (25 and 25 µM) an 97.1–99.3% 
reduction as compared with the untreated control cells (p<0.01) 
(Table 1). Aminophenols were far more toxic at low concentration than 
N-hydroxylamines, and N-hydroxy and aminophenol metabolites of 3.5-
DMA were more toxic than those of 2-6-DMA. Cell viability was 0.7% in 
TK6 cells 24 h after treatment with 25 µM of 3,5-DMAP (Table 1).
Cytotoxicity and mutagenicity of N-hydroxy and aminophenol 
metabolites of 2,6- and 3,5-DMA to TK6 cells
The alkylanilines proposed for the study are closely related structurally 
and would all likely be metabolized to N-hydroylamines in vivo [11]. 
A fraction of the alkylanilines may also be metabolically transformed to 
DNA reactive quinone imines [12]. Direct genotoxicity as a by-product 
of N-hydroxylamine or quinone imine formation is the expected 
carcinogenic mode of action for the chemicals [11,12]. In the present 
experiments, when TK6 cells were exposed for 1 h to N-hydroxy-2,6 
and 3,5-DMA, cell death was induced in a dose-dependent manner 
(Fig. 1a). N-hydroxy-3,5-DMA was more toxic than N-hydroxy-2,6-
DMA; cell viability was 44% in TK6 cells 1 h after a dose of 25 µM of 
N-hydroxy-3,5-DMA, as compared to 35% after treatment with 100 µM 
of N-hydroxy-2,6-DMA, respectively (arrows in Fig. 1a). Mutagenicity 
of N-hydroxy-2,6- and 3,5-DMA in the HPRT gene of TK6 cells was 
also investigated (Fig. 1b). At a dose of 100 µM in N-hydroxy-2,6-
DMA and 25 µM in N-hydroxy-3,5-DMA-treated TK6 cells, induced 
mutation frequencies in the HRPT gene were 1.31×10−5 (p<0.05) and 
1.73×10−5 (p<0.05), 3- and 4-fold higher than background (0.43×10−5), 
respectively (Fig. 1b).
A dose-dependent decrease in the viability of TK6 cells after treatment 
with 2,6- and 3,5-DMAP is shown in Fig. 2a. Aminophenol metabolites 
were more cytotoxic than N-hydroxy metabolites; cell viability in 
3,5- and 2,6-DMAP was 39 and 53% after a dose of 10 and 40 µM for 
Table 1: Cell survival after treatment with N-OH-2,6-DMA, N-OH-3,5-DMA, 2,6-DMA, P and 3,5-DMAP in TK6 cells
Dose (µM) Survival (%)
1 h 2 h 4 h 24 h
N-OH-2,6-DMA 0 100 100 100 100
50 57.4±3.10** 48.9±2.29** 40.4±2.12** 32.1±1.14**
100 35.4±1.21** 28.1±1.02** 19.4±1.29** 14.7±2.12**
250 19.9±1.04** 3.6±0.92** 5.7±0.44** 1.4±0.32**
N-OH-3,5-DMA 0 100 100 100 100
10 72.5±3.22* 69.3±3.41** 66.8±4.12** 62.3±2.35**
50 34.6±2.81** 21.3±2.04** 20.0±1.84** 17.9±0.89**
100 15.7±0.04** 7.9±0.23** 5.2±1.15** 2.9±0.51**
2,6-DMAP 0 100 100 100 100
5 82.8±3.21* 50.5±2.14** 45.2±2.87** 62.3±4.11**
10 60.1±3.46** 40.6±1.89** 33.0±1.25** 17.9±0.86**
25 42.9±2.56** 34.6±3.51** 19.9±2.88** 2.9±0.41**
3,5-DMAP 0 100 100 100 100
5 55.7±2.14** 53.5±3.14** 38.3±2.21** 36.3±2.10**
10 35.7±3.12** 29.5±1.12** 14.1±1.37** 19.1±0.98**
25 13.0±1.57** 7.1±0.91** 2.7±0.12** 0.7±0.04**
Each values is expressed as mean±standard deviation (n=3), *p<0.05 and **p<0.01 compared to vehicle control, DMAP: Dimethylaminophenol
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1 h (arrows in Fig. 2a), as compared to 44% and 35% after treatment 
with 25 µM of N-hydroxy-3,5-DMA and 100 µM of N-hydroxy-2,6-DMA, 
respectively (Fig. 1a). The MFs induced by exposure to 10 µM in 3,5-
DMAP and 40 µM in 2,6-DMAP for 1 h, 9.6 and 7.6×10−5 (p<0.01), were 
13- and 11-fold higher than the background MF, 0.69×10−5, respectively 
(Fig. 2b). By comparison, in 4-NQO-treated positive controls, MF at the 
HPRT locus was 1.24 and 1.4×10−5 (Figs. 1b and 2b).
ROS production by 3,5-DMAP
A growing body of evidence points toward oxygen-free radicals 
being involved in carcinogenesis and a wide variety of degenerative 
diseases  [13-15]. Oxidative damage may become a threat under 
conditions of oxidative stress, where defense and repair mechanisms are 
defective or are overwhelmed by the excessive generation of ROS [16]. 
Previous studies shown that the mechanism, by which the alkylanilines 
2,6-DMA and 3,5-DMA would generate ROS in vivo, involves initial 
oxidative metabolism to an aminophenol, which then can cycle through 
the corresponding quinone imine structure [5]. In the present study, the 
possible protective effects of SOD and CAT against the ROS-producing 
and cytotoxic effects of 3,5-DMAP were investigated by measuring 
intracellular ROS production and cell viability. As shown in Fig. 3, TK6 cells 
were exposed to 3,5-DMAP (5, 10, and 25 µM) for 24 h, and intracellular 
ROS production and cell survival were measured. Cell viability after 
treatment with 3,5-DMAP decreased by 42% at 5 µM, whereas inhibition 
of ROS with 500 U SOD and 500 U CAT restored the cell survival to a rate 
near that of control (81%). The chemical character of the ROS production 
from the samples treated with 2 mM of 3,5-DMAP as well as its changes 
caused by cotreatment with SOD and CAT was estimated based on the 
simulation of EPR spectra. The EPR peak height increased with increases 
in 3,5-DMAP (Fig. 3b). The addition of 500 U of SOD and CAT resulted 
in markedly decreases in EPR peak height, suggesting that removal of 
ROS generated from 3,5-DMAP (Fig. 3b). These data are consistent with 
the recent demonstration that both hydroxylamine and aminophenol 
metabolites of both 2,6- and 3,5-DMA were capable of producing ROS 
intracellularly and that the aminophenols were far more potent [5] and 
antioxidant enzymes such as N-acetyl cysteine, ascorbate, SOD, CAT, uric 
acid, and tiron rescue the incidence of 3,5-DMAP-induced mutagenesis in 
cultured mammalian cells [5,14].
CONCLUSION
The N-hydroxy and aminophenol metabolites of 2,6- and 3,5-DMA 
can cause both cytotoxicity and mutagenicity in the HPRT gene of 
TK6 cells. Our result also implicates ROS as mediators of 2,6- and 3,5-
DMA genotoxicity. Further research will be required to define more 
specifically the mechanisms through which they act.
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Fig. 1: Cell survival (a) and induced mutation fraction (b) in AS52 cells treated with N-hydroxy metabolites of 2,6-DMA and 3,5-DMA for 1 
h, results (a and b) are shown as the mean standard deviation (n=3), *p<0.05 and **p<0.01 compared to vehicle (DMSO) control
Fig. 2: Cell survival (a) and induced mutation fraction (b) in AS52 cells treated with aminophenol metabolites of 2,6-DMA and 3,5-DMA for 
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